Erika Newman

Dr. Newman, who joined the U-M faculty in 2010, focuses her career, both clinically and in the basic science laboratory, on finding innovative treatments for children with high-risk neuroblastoma. Her lab recently discovered that neuroblastoma cells utilize a non-canonical DNA repair pathway as a mechanism of tumor cell survival. Dr. Newman and her team are actively engaged in preclinical drug development and are currently collaborating on designing a series of highly promising small-molecules targeting aberrant DNA repair mechanisms in resistant neuroblastoma and in pediatric cancer.